Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-11-05Clinical Trial Update: Vaccine Therapy in Treating Patients With Recurrent Prostate Cancer [Phase 2]
Phase 2 clinical trial update evaluating a vaccine therapy for recurrent prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2019-11-04Clinical Trial Update: Paclitaxel and Bryostatin 1 in Treating Patients With Metastatic Prostate Cancer [Phase 2]
Phase 2 clinical trial of Paclitaxel and Bryostatin 1 in metastatic prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2019-11-04Clinical Trial Update: Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Prostate Cancer [Phase 2]
Phase 2 trial assessing combination chemotherapy with peripheral stem cell transplantation for metastatic prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2019-10-29Clinical Trial Update: Efficacy and Safety Study of Darolutamide (ODM-201) in Men With High-risk Non-metastatic Castration-resistant Prostate Cancer [Phase 3]
Phase 3 trial evaluating darolutamide in high-risk non-metastatic castration-resistant prostate cancer has completed with posted results in …
-
CLINICAL_TRIALS trial_result · 2019-10-22Clinical Trial Update: Phase I/II Hypofractionated Radiotherapy for Prostate Cancer [Phase 1, Phase 2]
Phase I/II trial investigating hypofractionated radiotherapy for prostate cancer completed with results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-10-21Clinical Trial Update: Enzalutamide and Niraparib in the Treatment of Metastatic Castrate-Resistant Prostate Cancer (CRPC) [Phase 1]
Phase 1 trial update investigating enzalutamide and niraparib for metastatic castration-resistant prostate cancer (CRPC) has been terminated…
-
CLINICAL_TRIALS trial_result · 2019-10-18Clinical Trial Update: Pilot Study of PLX3397 in Patients With Advanced Castration-Resistant Prostate Cancer (CRPC) [Phase 2]
Phase 2 pilot study of PLX3397 in advanced castration-resistant prostate cancer was terminated; results posted.
-
CLINICAL_TRIALS trial_result · 2019-10-16Clinical Trial Update: Interstitial Brachytherapy With or Without External-Beam Radiation Therapy in Treating Patients With Prostate Cancer [Phase 3]
Phase 3 trial comparing interstitial brachytherapy with or without external-beam radiation therapy for prostate cancer has completed. Result…
-
CLINICAL_TRIALS trial_result · 2019-10-09Clinical Trial Update: Ipilimumab + Androgen Depravation Therapy in Prostate Cancer [Phase 2]
Phase 2 trial update on ipilimumab combined with androgen deprivation therapy in prostate cancer; study terminated with posted results.
-
CLINICAL_TRIALS trial_result · 2019-10-08Clinical Trial Update: Enzalutamide/Leuprolide +/- Abiraterone/Pred in Prostate [Phase 2]
Phase 2 clinical trial update for enzalutamide with leuprolide ± abiraterone/pred in prostate cancer; results posted after completion.
-
CLINICAL_TRIALS trial_result · 2019-10-07Clinical Trial Update: Fluciclovine (18F) PET/CT in biochemicAL reCurrence Of Prostate caNcer [Phase 3]
Phase 3 trial update for fluciclovine (18F) PET/CT in biochemical recurrence of prostate cancer completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-10-04Clinical Trial Update: Safety and Efficacy Study of Dose-escalated Hypofractionated Radiotherapy For Prostate Cancer [Phase 1, Phase 2]
A dose-escalated hypofractionated radiotherapy trial for prostate cancer completed phases 1 and 2 to assess safety and efficacy.
-
CLINICAL_TRIALS trial_result · 2019-10-03Clinical Trial Update: A Phase 1 Study of MDV3100 in Patients With Castration-Resistant (Hormone-Refractory) Prostate Cancer [Phase 1]
Phase 1 trial update for MDV3100 (enzalutamide) in patients with castration-resistant (hormone-refractory) prostate cancer; study completed …
-
CLINICAL_TRIALS trial_result · 2019-10-02Clinical Trial Update: Denosumab Plus Enzalutamide, Abiraterone and Prednisone Compared to Denosumab Plus Enzalutamide Alone for Men With Castrate Resistant Prostate Cancer (CRPC) With Bone Metastases [Phase 2]
Phase 2 trial evaluating denosumab plus enzalutamide with or without abiraterone and prednisone in men with castration-resistant prostate ca…
-
CLINICAL_TRIALS trial_result · 2019-09-24Clinical Trial Update: Analyze the Predictive Value of Gene TMPRSS2-ETS in Response to Enzalutamide in Patients With Prostate Cancer [Phase 2]
Phase 2 trial assessing whether TMPRSS2-ETS gene status predicts response to enzalutamide in hormone-refractory prostate cancer.
-
CLINICAL_TRIALS trial_result · 2019-09-23Clinical Trial Update: Firmagon (Degarelix) Intermittent Therapy [Phase 4]
Phase 4 trial update for Degarelix (Firmagon) intermittent therapy in recurrent prostate cancer; study terminated.
-
CLINICAL_TRIALS trial_result · 2019-09-20Clinical Trial Update: Eradication of Prostate Cancer Using F-989 [Phase 2]
Phase 2 clinical trial evaluating F-989 for eradication of prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2019-09-18Clinical Trial Update: Impact of Robot-assisted Radical Prostatectomy Technique on Short-term Continence Recovery [Phase 3]
Phase 3 trial assessing robot-assisted radical prostatectomy and its effect on short-term continence recovery after surgery.
-
CLINICAL_TRIALS trial_result · 2019-09-18Clinical Trial Update: High-Dose Stereotactic Radiation for Prostate Cancer [NA]
A completed clinical trial evaluating high-dose stereotactic radiation for prostate cancer with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-09-17Clinical Trial Update: Fusion Targeted Biopsy of the Prostate [NA]
Completed clinical trial on fusion-targeted biopsy for prostate cancer; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-09-13Clinical Trial Update: Phase I Study of Intensity Modulated Radiation Therapy for Prostate Cancer [Phase 1]
Phase I trial evaluating intensity modulated radiation therapy for prostate cancer; study terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2019-09-11Clinical Trial Update: TKI258 in Castrate Resistant Prostate Cancer [Phase 2]
Phase 2 clinical trial update for TKI258 in castration-resistant prostate cancer; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-09-11Clinical Trial Update: Miami Membrane for Potency (MMEP) Trial [Phase 2]
Phase 2 trial of Miami Membrane for Potency (MMEP) in prostate cancer was terminated; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-08-22Clinical Trial Update: Stereotactic Radiation Therapy in Treating Patients With Prostate Cancer [NA]
Clinical trial update for stereotactic radiation therapy in prostate cancer; study terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2019-08-21Clinical Trial Update: Temsirolimus and Bevacizumab in Hormone-Resistant Metastatic Prostate Cancer That Did Not Respond to Chemotherapy [Phase 1, Phase 2]
Phase 1/2 trial evaluating temsirolimus with bevacizumab in hormone-resistant metastatic prostate cancer that failed chemotherapy has comple…